{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:36:03Z","timestamp":1787063763130,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025244","name":"Utah Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025244","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ajt.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T22:10:08Z","timestamp":1713478208000},"page":"1784-1793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4588-9224","authenticated-orcid":false,"given":"Amanda","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8146-5955","authenticated-orcid":false,"given":"Luke","family":"Kosinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3388-7747","authenticated-orcid":false,"given":"Alexandre","family":"Loupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-0792","authenticated-orcid":false,"given":"Mark","family":"Stegall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2954-2538","authenticated-orcid":false,"given":"Ilkka","family":"Helanter\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4766-1888","authenticated-orcid":false,"given":"Kenneth","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig-Ulf","family":"Meier-Kriesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-3680","authenticated-orcid":false,"given":"Roslyn B.","family":"Mannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6189-5499","authenticated-orcid":false,"given":"William E.","family":"Fitzsimmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajt.2024.04.004_bib1","series-title":"Committee for Medicinal Products for Human Use (CHMP) Guideline on Clinical Investigation of Immunosuppressants for Solid Organ Transplantation Draft Agreed by Efficacy Working Party End of Consultation (Deadline for Comments)","year":"2007"},{"issue":"3","key":"10.1016\/j.ajt.2024.04.004_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/TP.0000000000004696","article-title":"Acute rejection after kidney transplant-an endpoint not predictive of treatment effect on graft survival","volume":"108","author":"Fitzsimmons","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2024.04.004_bib3","unstructured":"Highlights of Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/204096s003s004lbl.pdf. Accessed 1 March 2024."},{"key":"10.1016\/j.ajt.2024.04.004_bib4","unstructured":"Highlights of Prescribing Information. These Highlights Do Not Include All the Information Needed to Use PROGRAF Safely and Effectively. See Full Prescribing Information for PROGRAF. PROGRAF (Tacrolimus) Capsules PROGRAF (Tacrolimus) Injection, (for Intravenous Use). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/050709s031lbl.pdf. Accessed 1 March 2024."},{"key":"10.1016\/j.ajt.2024.04.004_bib5","unstructured":"Highlights of Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/206406s007lbl.pdf. Accessed 1 March 2024."},{"issue":"3","key":"10.1016\/j.ajt.2024.04.004_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/ajt.16883","article-title":"The negative impact of T cell-mediated rejection on renal allograft survival in the modern era","volume":"22","author":"Rampersad","year":"2022","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2024.04.004_bib7","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ajt.2023.04.018","article-title":"Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes","volume":"23","author":"Klein","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2024.04.004_bib8","unstructured":"Qualification opinion for the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/qualification-opinion-ibox-scoring-system-secondary-efficacy-endpoint-clinical-trials-investigating-novel-immunosuppressive-medicines-kidney-transplant-patients_en.pdf."},{"key":"10.1016\/j.ajt.2024.04.004_bib9","article-title":"Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study","volume":"366","author":"Loupy","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ajt.2024.04.004_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A\u00a0phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2024.04.004_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","article-title":"Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients","volume":"12","author":"Vincenti","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2024.04.004_bib12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1600-6143.2011.03914.x","article-title":"Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys","volume":"12","author":"Pestana","year":"2012","journal-title":"Am J Transplant"},{"issue":"19","key":"10.1016\/j.ajt.2024.04.004_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin c-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ajt.2024.04.004_bib14","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1177\/0962280213497434","article-title":"Assessing calibration of prognostic risk scores","volume":"25","author":"Crowson","year":"2016","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"10.1016\/j.ajt.2024.04.004_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.ajt.2024.04.004_bib16","series-title":"Modelling Survival Data in Medical Research","author":"Collett","year":"2015"},{"issue":"11","key":"10.1016\/j.ajt.2024.04.004_bib17","first-page":"1","article-title":"cutpointr: improved estimation and validation of optimal cutpoints in R","volume":"98","year":"2021","journal-title":"J\u00a0Stat Softw"},{"issue":"5","key":"10.1016\/j.ajt.2024.04.004_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2016.34","article-title":"Transplantation: BENEFIT of belatacept: kidney transplantation moves forward","volume":"12","author":"Naesens","year":"2016","journal-title":"Nat Rev Nephrol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524002752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524002752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:50:50Z","timestamp":1759351850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613524002752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1600613524002752"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2024.04.004","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2024.04.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}